Recombinant Mouse IL-22 Protein , N-His

Interleukin-22 (IL-22) is a cytokine primarily produced by various immune cells, including Th17 cells, innate lymphoid cells, and specific T cells. It plays a critical role in the immune response, particularly in mucosal immunity and tissue homeostasis. Research has highlighted IL-22's involvement in the pathogenesis of numerous inflammatory and autoimmune diseases, such as psoriasis, rheumatoid arthritis, and inflammatory bowel disease (IBD). The recombinant form of IL-22 has gained attention as a potential therapeutic agent due to its ability to promote tissue repair and enhance the protective functions of epithelial cells. It acts by signaling through the IL-22 receptor, influencing the expression of genes that regulate cellular proliferation, survival, and antimicrobial responses. Understanding the precise mechanisms through which IL-22 operates can open new avenues for treatment strategies, aiming to modulate immune responses and promote healing in affected tissues. Furthermore, the characterization and production of recombinant IL-22 have facilitated various preclinical and clinical studies to explore its efficacy and safety, contributing to the broader field of cytokine-based therapies. The ongoing research seeks to clarify the dual roles of IL-22 in both protective immunity and pathological inflammation, which is crucial for developing targeted therapies that leverage its therapeutic potential while minimizing adverse effects.